Phase III trial of abuse-resistant oxycodone [Remoxy; Pain Therapeutics] in patients with moderate to severe osteoarthritis pain.

Trial Profile

Phase III trial of abuse-resistant oxycodone [Remoxy; Pain Therapeutics] in patients with moderate to severe osteoarthritis pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2010

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors King Pharmaceuticals; Pain Therapeutics
  • Most Recent Events

    • 20 Aug 2008 Results presented at 12th World Congress of the International Association for the Study of Pain (IASP) in August 2008.
    • 07 Dec 2007 Status changed from in progress to completed.
    • 06 Dec 2007 Preliminary data available; primary endpoint achieved. Pain Therapeutics expect to file a New Drug Application to the US FDA in the second quarter of 2008, based on the results of this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top